YIH
RDY icon

Y-Intercept (HK)’s Dr. Reddy's Laboratories RDY Stock Holding History

Y-Intercept (HK)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,660
Closed -$450K – 1831
2024
Q1 		$450K Buy
+30,660
New +$448K 0.03% 767
2023
Q4 		– Sell
-22,910
Closed -$306K – 1584
2023
Q3 		$306K Buy
+22,910
New +$310K 0.03% 760
2023
Q2 		– Sell
-43,740
Closed -$498K – 1645
2023
Q1 		$498K Buy
+43,740
New +$472K 0.06% 535

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Y-Intercept (HK)'s RDY Position: Q2 2024 in Review

Y-Intercept (HK) sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 30,660 shares — an estimated $450K sold.

Y-Intercept (HK) first reported a position in RDY in Q1 2023 and held it in 3 quarters. The position peaked at $498K in Q1 2023. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • Y-Intercept (HK) reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 30,660 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $450K.
  • Y-Intercept (HK) first reported a position in Dr. Reddy's Laboratories in Q1 2023 and held it in 3 quarters.
  • Y-Intercept (HK)'s Dr. Reddy's Laboratories position peaked at $498K in Q1 2023.
  • 222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Y-Intercept (HK)'s 13F filing for Q2 2024, filed 14 Aug 2024.